nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—posterior vena cava—testicular cancer	0.599	0.672	CbGeAlD
Ximelagatran—F2—vein—testicular cancer	0.264	0.297	CbGeAlD
Ximelagatran—CYP2C9—Ifosfamide—testicular cancer	0.0738	0.673	CbGbCtD
Ximelagatran—CYP2C9—Cisplatin—testicular cancer	0.0359	0.327	CbGbCtD
Ximelagatran—F2—female gonad—testicular cancer	0.0276	0.031	CbGeAlD
